+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

The Asia-Pacific Pharmaceuticals Sectors : A Company and Industry Analysis (March 2005)

  • ID: 656342
  • Report
  • March 2005
  • 36 pages
  • Mergent
1 of 4
This report examines the oil and gas sectors in Europe, focusing on the key markets of France, Germany, Norway, Russia, Spain and the United Kingdom
Current Environment - Key Points
- Increased pharmaceutical spending and drug exports contributed to rising sales revenue and improved profits for most major pharmaceutical firms across the Asia-Pacific region
- Rising healthcare and medical expenditure resulted in some Asian governments implementing budget control measures and promoting the greater use of generics
- Lower costs together with the availability of skilled workers prompted a number of multinational pharmaceutical manufacturers to invest in the establishment of regional offices and research facilities, particularly in China
- A high level of merger and acquisition activity took place in Asia-Pacific as domestic and international drug makers responded to a stiff competitive market and tried to maintain a lead over rivals
- The initial public offering for India's Indoco Remedies Ltd (NSE: INDOCO) in December 2004 received an overwhelming response, with shares oversubscribed 60.7 times

Industry Profile - Key Points
- Pharmaceutical sales for the Asia-Pacific (including Africa) in 2004 amounted to US$98 billion or 18.8% of global pharmaceutical sales
- As one of the fastest growing countries in Asia and with a flourishing economy, China expects to see sales from its pharmaceutical sector surge by 24% this year, driven by a rising population and higher demand for healthcare services and products
- All eyes are on Singapore's growing biomedical industry, which is fast becoming one of the country's key sectors and has the potential to boost Asia's pharmaceutical industry
- Residents from Cambodia, Vietnam, Thailand and Hong Kong are worried as their lives are being threatened by the killer Avian influenza which has resurfaced again, causing a series of deaths in Cambodia and Vietnam
- Approximately 5.1 million Indians are infected with HIV, the highest number of infections in Asia- Pacific
The number of people with HIV in the region has increased by approximately one million in 2004 from 2002
- More Asian countries have made an effort to tighten intellectual property protection laws, providing relief to international drug makers, which are worried about the safety of the information relating to their drug formulation
Market Trends and Outlook - Key Points
- With approximately 100 drug patents expiring this year, including blockbuster drugs, the Asian generics sector will benefit and increase its pipeline of products
- A relatively new technology is making its appearance into the pharmaceutical scene - nanotechnology, which quickens drug discovery research and drug delivery to patients
- The clinical trials outsourcing market in Asia-Pacific is expected to grow further and continue to attract foreign drug makers as it offers low costs and good testing facilities, particularly in Japan and India
- As competition becomes tougher, the number of merger and acquisition activities in the pharmaceutical industry increases
- The pharmaceutical industry will remain a hot industry for Asia-Pacific while smaller markets such as Malaysia and the Philippines work their way up and develop into more mature markets such as those in Japan, India and China

Note: Product cover images may vary from those shown
2 of 4


3 of 4
Current Environment
- Sector Overview
- Leading Drug Makers
- Initial Public Offerings
- Merger, Acquisition and
Alliance Activities
- Research and Development
Industry Profile
- Industry Size and Value
- Industry Focus
- Threat of an Avian Influenza
- Access to HIV/AIDS drugs
- Cures Through Stem Cell
- Policy and Regulatory
Market Trends & Outlook
- Generics Pharmaceutical
- Nanotechnology - Aiding
- More Clinical Trials
- Market Outlook
Country Profiles
- Australia
- China
- India
- Japan
- South Korea
- Taiwan
Currency Conversion Table
The Scope of this Report
Key References
Comparative Data
Sales Contacts

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown